Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-20

FDA Approved: PRASUGREL — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Amneal's supplemental application for prasugrel, enabling a generic version of the antiplatelet drug. The approval is for the same indications as t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRASUGREL (prasugrel)

Snippet

SUPPL AP for PRASUGREL (PRASUGREL)